Advertisement
Screener

CHEMED CORPORATION (CHE) Business Acquisition, Pro Forma Net Income (Loss)

2.4 / 5 stars · 57/120 Roast Me

CHEMED CORPORATION Business Acquisition, Pro Forma Net Income (Loss)

CHEMED CORPORATION (CHE) reported Business Acquisition, Pro Forma Net Income (Loss) of $67.72 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-04.

Discontinued › Expense Statement › Operating Expenses

us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2021-02-26

  • CHEMED CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2020-09-30 was $67.72M, a 8.89% increase year-over-year.
  • CHEMED CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2020-06-30 was $82.13M, a 50.73% increase year-over-year.
  • CHEMED CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2019-12-31 was $64.26M, a 10.39% increase year-over-year.
  • CHEMED CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2019-09-30 was $62.19M, a 10.26% increase year-over-year.
  • CHEMED CORPORATION business acquisition, pro forma net income (loss) for fiscal 2019 was $228.94M, a 1.82% increase from fiscal 2018.
  • CHEMED CORPORATION business acquisition, pro forma net income (loss) for fiscal 2018 was $224.85M.
Period endBusiness Acquisition, Pro Forma Net Income (Loss) 3 monthBusiness Acquisition, Pro Forma Net Income (Loss) 3 month as first filedBusiness Acquisition, Pro Forma Net Income (Loss) 6 monthBusiness Acquisition, Pro Forma Net Income (Loss) 9 monthBusiness Acquisition, Pro Forma Net Income (Loss) 9 month as first filedBusiness Acquisition, Pro Forma Net Income (Loss) 12 month
2020-09-30$67.72M
10-Q · filed 2020-11-04
$149.85M
derived: sum of 2 quarters · filed 2020-11-04
$205.77M
10-Q · filed 2020-11-04
2020-06-30$82.13M
10-Q · filed 2020-07-31
$138.05M
10-Q · filed 2020-07-31
2019-12-31$64.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$126.45M
derived: sum of 2 quarters · filed 2021-02-26
$180.94M
derived: sum of 3 quarters · filed 2021-02-26
$228.94M
10-K · filed 2021-02-26
2019-09-30$62.19M
10-Q · filed 2020-11-04
$62.15M
10-Q · filed 2019-11-04
$116.69M
derived: sum of 2 quarters · filed 2020-11-04
$164.68M
10-Q · filed 2020-11-04
$164.56M
10-Q · filed 2019-11-04
$222.83M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$54.49M
10-Q · filed 2020-07-31
$102.47M
10-Q · filed 2020-07-31
$160.64M
derived: sum of 3 quarters · filed 2021-02-26
$217.05M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$47.94M
10-Q · filed 2020-05-01
$106.15M
derived: sum of 2 quarters · filed 2021-02-26
$162.56M
derived: sum of 3 quarters · filed 2021-02-26
2018-12-31$58.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$114.62M
derived: sum of 2 quarters · filed 2021-02-26
$224.85M
10-K · filed 2021-02-26
2018-09-30$56.41M
10-Q · filed 2019-11-04
$166.64M
10-Q · filed 2019-11-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Option Care Health, Inc. (OPCH)United States$3.602B20.52
Aveanna Healthcare Holdings, Inc. (AVAH)United States$2.703B7.22
Addus HomeCare Corp (ADUS)United States$2.129B17.80
BrightSpring Health Services, Inc. (BTSG)United States$11.078B37.65
AdaptHealth Corp. (AHCO)United States$0.759B-6.22